Bjørn Naume, Breast cancer treatment programme

Publications published since 1991 or in press by Bjørn Naume

49 publications found

Publications in press

1. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B
   Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
   Breast Cancer Res Treat (in press)
   PubMed 20449649
2. Van Belle V, Van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P
   Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis
   J Clin Oncol (in press)
   PubMed 20713855

Publications 2010

1. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L (2010)
   NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
   Mol Cancer, 9, 113
   PubMed 20482849
2. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
   Mol. Oncol., 4 (2), 169
3. Nesvold IL, Fosså SD, Holm I, Naume B, Dahl AA (2010)
   Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life
   Acta Oncol, 49 (3), 347-53
   PubMed 19842790
4. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
   Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
   Sci Transl Med, 2 (38), 38ra47
   PubMed 20592421

Publications 2009

1. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
   Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
   Histol Histopathol, 24 (8), 1049-59
   PubMed 19554512
2. Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S (2009)
   A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide
   Clin Cancer Res, 15 (12), 4165-73
   PubMed 19509150
3. Kamalakaran S, Kendall J, Zhao X, Tang C, Khan S, Ravi K, Auletta T, Riggs M, Wang Y, Helland A, Naume B, Dimitrova N, Børresen-Dale AL, Hicks J, Lucito R (2009)
   Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation
   Nucleic Acids Res, 37 (12), e89
   PubMed 19474344
4. Nesvold IL, Fosså SD, Naume B, Dahl AA (2009)
   Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors
   Breast Cancer Res Treat, 117 (2), 281-8
   PubMed 19112616
5. Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T (2009)
   The prognostic impact of occult nodal metastasis in early breast carcinoma
   Breast Cancer Res Treat, 118 (1), 57-66
   PubMed 19219629

Publications 2008

1. Baumbusch LO, Aarøe J, Johansen FE, Hicks J, Sun H, Bruhn L, Gunderson K, Naume B, Kristensen VN, Liestøl K, Børresen-Dale AL, Lingjaerde OC (2008)
   Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
   BMC Genomics, 9, 379
   PubMed 18691401
2. Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL (2008)
   Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
   J Pathol, 214 (3), 357-67
   PubMed 18044827
3. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
   Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
   Clin Cancer Res, 14 (8), 2341-50
   PubMed 18413823
4. Nordgard SH, Johansen FE, Alnaes GI, Bucher E, Syvänen AC, Naume B, Børresen-Dale AL, Kristensen VN (2008)
   Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients
   Genes Chromosomes Cancer, 47 (8), 680-96
   PubMed 18398821

Publications 2007

1. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
   Mol Oncol, 1 (2), 160-71
   PubMed 19383292
2. Nordgard SH, Johansen FE, Alnaes GI, Naume B, Børresen-Dale AL, Kristensen VN (2007)
   Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
   Breast Cancer Res, 9 (6), 113
   PubMed 18036273
3. Wiedswang G, Naume B (2007)
   Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer?
   Nat Clin Pract Oncol, 4 (3), 154-5
   PubMed 17290243

Publications 2006

1. Borgen E, Pantel K, Schlimok G, Müller P, Otte M, Renolen A, Ehnle S, Coith C, Nesland JM, Naume B (2006)
   A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow
   Cytometry B Clin Cytom, 70 (6), 400-9
   PubMed 16924637
2. Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E (2006)
   A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
   Cancer, 107 (5), 885-92
   PubMed 16874814
3. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Børresen-Dale AL, Naume B, Schlicting E, Norton L, Hägerström T, Skoog L, Auer G, Månér S, Lundin P, Zetterberg A (2006)
   Novel patterns of genome rearrangement and their association with survival in breast cancer
   Genome Res, 16 (12), 1465-79
   PubMed 17142309
4. Muggerud AA, Johnsen H, Barnes DA, Steel A, Lønning PE, Naume B, Sørlie T, Børresen-Dale AL (2006)
   Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes
   BMC Cancer, 6, 59
   PubMed 16536878
5. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL (2006)
   Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
   BMC Genomics, 7, 127
   PubMed 16729877
6. Wiedswang G, Borgen E, Schirmer C, Kåresen R, Kvalheim G, Nesland JM, Naume B (2006)
   Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
   Int J Cancer, 118 (8), 2013-9
   PubMed 16287086

Publications 2005

1. Braun S, Naume B (2005)
   Circulating and disseminated tumor cells
   J Clin Oncol, 23 (8), 1623-6
   PubMed 15755968
2. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K (2005)
   A pooled analysis of bone marrow micrometastasis in breast cancer
   N Engl J Med, 353 (8), 793-802
   PubMed 16120859

Publications 2004

1. Naume B, Borgen E, Tøssvik S, Pavlak N, Oates D, Nesland JM (2004)
   Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method
   Cytotherapy, 6 (3), 244-52
   PubMed 15203981
2. Naume B, Wiedswang G, Borgen E, Kvalheim G, Kåresen R, Qvist H, Janbu J, Harbitz T, Nesland JM (2004)
   The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells
   Clin Cancer Res, 10 (9), 3091-7
   PubMed 15131048
3. Wiedswang G, Borgen E, Kåresen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B (2004)
   Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome
   Clin Cancer Res, 10 (16), 5342-8
   PubMed 15328170

Publications 2003

1. Wiedswang G, Borgen E, Karesen R, Naume B (2003)
   Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed
   Cytotherapy, 5 (1), 40-5
   PubMed 12745581
2. Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B (2003)
   Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
   J Clin Oncol, 21 (18), 3469-78
   PubMed 12972522

Publications 2001

1. Borgen E, Naume B, Nesland JM, Nowels KW, Pavlak N, Ravkin I, Goldbard S (2001)
   Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples
   Cytometry, 46 (4), 215-21
   PubMed 11514954
2. Naume B, Borgen E, Kvalheim G, Kåresen R, Qvist H, Sauer T, Kumar T, Nesland JM (2001)
   Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics
   Clin Cancer Res, 7 (12), 4122-9
   PubMed 11751511
3. Wiedswang G, Naess AB, Naume B, Kåresen R (2001)
   Micrometastasis to axillary lymph nodes and bone marrow in breast cancer patients
   Breast, 10 (3), 237-42
   PubMed 14965591

Publications 1999

1. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K (1999)
   Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
   Cytotherapy, 1 (5), 377-88
   PubMed 20426539
2. Kvalheim G, Naume B, Nesland JM (1999)
   Minimal residual disease in breast cancer
   Cancer Metastasis Rev, 18 (1), 101-8
   PubMed 10505549

Publications 1998

1. Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B (1998)
   Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
   J Pathol, 185 (4), 427-34
   PubMed 9828843
2. Naume B (1998)
   [New methods for early detection of breast cancer metastasis]
   Tidsskr Nor Laegeforen, 118 (3), 354
   PubMed 9499719
3. Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G (1998)
   Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
   Int J Cancer, 78 (5), 556-60
   PubMed 9808522

Publications 1997

1. Naume B, Borgen E, Beiske K, Herstad TK, Ravnås G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S, Kvalheim G (1997)
   Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood
   J Hematother, 6 (2), 103-14
   PubMed 9131439

Publications 1995

1. Fosså SD, Aamdal S, Naume B, Gallati H (1995)
   Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
   Acta Oncol, 34 (5), 599-603
   PubMed 7546824

Publications 1994

1. Naume B, Espevik T (1994)
   Immunoregulatory effects of cytokines on natural killer cells
   Scand J Immunol, 40 (2), 128-34
   PubMed 8047834

Publications 1993

1. Borset M, Helseth E, Naume B, Waage A (1993)
   Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation
   Br J Haematol, 85 (3), 446-51
   PubMed 8136264
2. Naume B, Gately MK, Desai BB, Sundan A, Espevik T (1993)
   Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation
   Cytokine, 5 (1), 38-46
   PubMed 8097934
3. Naume B, Johnsen AC, Espevik T, Sundan A (1993)
   Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12
   Eur J Immunol, 23 (8), 1831-8
   PubMed 7688307

Publications 1992

1. Naume B, Gately M, Espevik T (1992)
   A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells
   J Immunol, 148 (8), 2429-36
   PubMed 1373169

Publications 1991

1. Naume B, Espevik T (1991)
   Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study
   J Immunol, 147 (7), 2208-14
   PubMed 1717551
2. Naume B, Nonstad U, Steinkjer B, Funderud S, Smeland E, Espevik T (1991)
   Immunomagnetic isolation of NK and LAK cells
   J Immunol Methods, 136 (1), 1-9
   PubMed 1704900
3. Naume B, Shalaby R, Lesslauer W, Espevik T (1991)
   Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells
   J Immunol, 146 (9), 3045-8
   PubMed 1707931